CD19 and COVID-19: Consistent with the increase in IgG-anti COVID-19, a significant increase in CD19+ B cell percentages was observed (2-fold after the second dose and 2.85-fold after the booster dose, p = 0.033), reflecting B cell activation following vaccination.